Shattuck Labs, Inc. Stock-Based Compensation
Shattuck Labs, Inc. (STTK) reported Stock-Based Compensation of $5.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.73M, a 44.60% increase year-over-year.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.42M, a 40.33% increase year-over-year.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.61M, a 13.19% decline year-over-year.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.78M, a 30.44% decline year-over-year.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $7.00M, a 26.72% decline from fiscal 2024.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $9.55M, a 37.57% increase from fiscal 2023.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $6.94M, a 7.38% increase from fiscal 2022.
- Shattuck Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $6.46M, a 18.20% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $5.15M 10-Q · filed 2026-08-11 | $6.75M derived: sum of 3 quarters · filed 2026-08-11 | $8.53M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.42M 10-Q · filed 2026-05-07 | $4.02M derived: sum of 2 quarters · filed 2026-05-07 | $5.80M derived: sum of 3 quarters · filed 2026-05-07 | $7.69M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.38M derived: sum of 2 quarters · filed 2026-03-05 | $5.27M derived: sum of 3 quarters · filed 2026-08-11 | $7.00M 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.67M derived: sum of 2 quarters · filed 2026-08-11 | $5.39M 10-Q · filed 2025-11-06 | $7.24M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.61M 10-Q · filed 2026-08-11 | $5.46M derived: sum of 3 quarters · filed 2026-08-11 | $8.02M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.72M 10-Q · filed 2026-05-07 | $3.57M derived: sum of 2 quarters · filed 2026-05-07 | $6.13M derived: sum of 3 quarters · filed 2026-05-07 | $8.79M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.41M derived: sum of 2 quarters · filed 2026-03-05 | $7.07M derived: sum of 3 quarters · filed 2026-03-05 | $9.55M 10-K · filed 2026-03-05 |
| 2024-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.22M derived: sum of 2 quarters · filed 2025-11-06 | $7.70M 10-Q · filed 2025-11-06 | $9.34M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $5.14M 10-Q · filed 2025-08-14 | $6.78M derived: sum of 3 quarters · filed 2025-08-14 | $8.54M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-01 | $4.12M derived: sum of 2 quarters · filed 2025-05-01 | $5.88M derived: sum of 3 quarters · filed 2025-05-01 | $7.73M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $3.40M derived: sum of 2 quarters · filed 2025-03-27 | $5.26M derived: sum of 3 quarters · filed 2025-03-27 | $6.94M 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.62M derived: sum of 2 quarters · filed 2024-11-14 | $5.30M 10-Q · filed 2024-11-14 | $6.99M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.54M 10-Q · filed 2024-08-01 | $5.23M derived: sum of 3 quarters · filed 2024-08-01 | $6.95M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $1.68M 10-Q · filed 2024-05-02 | $3.38M derived: sum of 2 quarters · filed 2024-05-02 | $5.10M derived: sum of 3 quarters · filed 2024-05-02 | $6.63M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.42M derived: sum of 2 quarters · filed 2024-02-29 | $4.95M derived: sum of 3 quarters · filed 2024-02-29 | $6.46M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.26M derived: sum of 2 quarters · filed 2023-11-09 | $4.77M 10-Q · filed 2023-11-09 | $5.99M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.05M 10-Q · filed 2023-08-10 | $4.26M derived: sum of 3 quarters · filed 2023-08-10 | $5.61M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.51M 10-Q · filed 2023-05-09 | $2.73M derived: sum of 2 quarters · filed 2023-05-09 | $4.07M derived: sum of 3 quarters · filed 2023-05-09 | $5.80M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.56M derived: sum of 2 quarters · filed 2023-02-23 | $4.29M derived: sum of 3 quarters · filed 2023-02-23 | $5.47M 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.07M derived: sum of 2 quarters · filed 2022-11-09 | $4.25M 10-Q · filed 2022-11-09 | $4.89M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.91M 10-Q · filed 2022-08-11 | $3.54M derived: sum of 3 quarters · filed 2022-08-11 | $3.86M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.18M 10-Q · filed 2022-05-12 | $1.82M derived: sum of 2 quarters · filed 2022-05-12 | $2.13M derived: sum of 3 quarters · filed 2022-05-12 | $2.27M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $949.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.09M derived: sum of 3 quarters · filed 2022-03-15 | $1.27M 10-K · filed 2022-03-15 |
| 2020-09-30 | $312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $455.00K derived: sum of 2 quarters · filed 2021-11-09 | $629.00K 10-Q · filed 2021-11-09 | $793.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $317.00K 10-Q · filed 2021-08-12 | $481.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $174.00K 10-Q · filed 2021-05-10 | $338.00K derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $461.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $297.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |